Autoimmune Hepatitis. Hili N. Morillas, MD November 1, 2004 Morning Report

Size: px
Start display at page:

Download "Autoimmune Hepatitis. Hili N. Morillas, MD November 1, 2004 Morning Report"

Transcription

1 Autoimmune Hepatitis Hili N. Morillas, MD November 1, 2004 Morning Report

2 Definition! An unresolving inflammation of unknown cause.! Characterized by the presence of interface hepatitis and portal plasma cell infiltration, hypergammaglobulinemia, and autoantibodies.

3 Differential Diagnosis! Wilson s Disease! Chronic viral hepatitis! α 1 -antitrypsin deficiency! Drug induced liver injury! Genetic hemochromatosis

4 Clinical Manifestations! May present at any age and in either sex! Occurs most frequently in women between the ages of or in late middle age! Can mimic acute viral hepatitis! Insidious onset! May not be recognized until liver damage is advanced

5 Clinical Manifestations! Common symptoms at presentation: - Fatigue (85%) - Abdominal pain (10-40%) - Anorexia (20%) - Fever (20%)! Common physical findings: - Hepatomegaly (78%) - Jaundice (69%) - Decompensated cirrhosis (10 to 20%)

6 Extrahepatic Manifestations! Occur frequently! Maculopapular skin rashes (20%) - Allergic capillaritis - Lichen planus - Leg ulcers - Vitiligo! Synovitis (6-36%)

7 Extrahepatic Manifestations! Increased incidence of autoimmune diseases: - Autoimmune thyroiditis - Sjogren s syndrome - Renal tubular acidosis - Glomerulonephritis - Peripheral neuropathy - Fibrosing alveolitis

8 Epidemiology! Annual incidence in Northern Europeans is 1.9/100,000.! Point prevalence is 16.9/100,000.! 5.9% of transplantations in the U.S.! Women are affected more than men, 3.6:1! All ages and ethnic groups are susceptible.

9 Natural History! Acute onset of illness is common (40%).! 40% of patients with severe untreated disease die within 6 months of diagnosis.! Cirrhosis develops in at least 40% of survivors.! Less severe lab and histological findings still develop cirrhosis 49% within 15 years.! Hepatic failure in 10%.

10 Diagnosis! Liver biopsy is essential to establish diagnosis, disease severity, and the need for treatment.! Interface hepatitis is the histologic hallmark with portal plasma cell infiltration.! However, this is not disease specific.

11 Interface Hepatitis Intense lymphoplasmacytic infiltrate expanding portal area and infiltrating across the limiting plate into the adjacent lobule

12 More Histology The portal infiltrate is very plasma cell rich, a pattern commonly seen in autoimmune hepatitis.

13 Diagnosis! Autoantibodies must be present Not pathogenic nor disease specific Expression can vary during disease course Low titers don t exclude disease High titers don t establish the diagnosis Levels do not reflect treatment response! Serologic markers are: ANA, SMA, and anti-lkm1

14 Autoantibodies associated with AIH! ANA is the traditional marker for AIH (67%) Alone 13% SMA 54%! SMA present in 87% of pts with AIH Alone (33%)! Anti-LKM1 Typically occurs in the absence of ANA and SMA

15 Classification of AIH! Type 1 Most common Associated with ANA or SMA All ages affected Associated with panca! Type 2 Characterized by anti-lkm1 More common in Europe and South America Not associated with panca! Type 3 Anti-SLA/LP (soluble liver antigen/liver pancreas) Same clinical features as type 1

16 Diagnostic Criteria for AIH Requisites Genetic Liver Disease Definite Nl α 1 -antitrypsin, ceruloplasmin, iron, ferritin Probable Partial α 1 -antitrypsin deficiency; copper, ceruloplasmin, iron, ferritin level abnormality No active viral infection Hep A, B, C markers negative Hep A, B, C markers negative Toxin and alcohol injury Alcohol < 25g/d No hepatotoxic drug use. Alcohol < 50g/d No hepatotoxic drug use. Lab Features Autoantibodies AST/ALT, IgG > 1.5 times normal ANA, SMA, anti-lkm1 > 1:80 AST/ALT, hypergammaglobulinemia of any level ANA, SMA, anti-lkm1 > 1:40 Histologic Findings Interface hepatitis Interface hepatitis

17 AASLD Recommendations! Dx of AIH requires determination of serum aminotransferase and γ-globulin levels; detection of ANA/SMA or anti-lkm1; liver tissue examination! Diagnostic criteria should be applied to all patients! If diagnosis is not clear, scoring method should be used

18 Treatment Indications! Serum AST > 10-fold upper limit of normal! Serum AST > 5-fold upper limit of normal and γ-globulin level > twice normal! Histologic features of necrosis

19 Treatment Regimens! Prednisone Alone! Low dose prednisone with azathioprine Preferred treatment regimen Lower rate of corticosteroid induced side effects! Continue treatment until remission, treatment failure, incomplete response or drug toxicity

20 Treatment Regimen Treatment Week Week 1 Week 2 Week 3 Week 4 Maintenance Prednisone (mg/d) Combination Prednisone (mg/d) with Azathioprine (50 mg/d)

21 Treatment! Complications of Prednisone! Usually after more than 18 months of chronic use and doses that exceed 10 mg daily Vertebral compression Diabetes Cataracts Hypertension Psychosis Osteoporosis

22 Treatment! Complications of azathioprine! Develop in less than 10% of patients taking 50 mg daily Cholestatic hepatitis Veno-occlusive disease Pancreatitis Nausea and emesis Rash Bone marrow suppression

23 Treatment! Prednisone alone Cytopenias Short treatment course (< 6 months) Pregnancy Active malignancy Thiopurine methyltransferase deficiency! Combination therapy Postmenopausal Osteoporosis Brittle diabetes Obesity Acne Emotional lability Hypertension

24 Treatment Endpoints! No minimum or maximum duration of treatment! Remission connotes disappearance of symptoms, improvement of AST to less than twice the normal level and improvement of liver tissue to normal.! Patients should be given opportunity to enter remission after clinical, laboratory or histologic resolution! Histologic improvement lags behind by 3-6 months

25 References! Czaja and Freese. Diagnosis and Treatment of Autoimmune Hepatitis. Hepatology, Vol. 36, No. 2, 2002.! Up To Date

Autoimmune Hepatitis. What is autoimmune hepatitis? Autoimmune hepatitis affects the liver.

Autoimmune Hepatitis. What is autoimmune hepatitis? Autoimmune hepatitis affects the liver. Autoimmune Hepatitis What is autoimmune hepatitis? Autoimmune hepatitis affects the liver. Autoimmune hepatitis is a disease in which the body s immune system attacks liver cells. This immune response

More information

Autoimmune Hepatitis. Autoimmune Disease

Autoimmune Hepatitis. Autoimmune Disease Autoimmune Hepatitis Autoimmune Hepatitis Autoimmune hepatitis is a disease in which the body's immune system attacks liver cells. This causes the liver to become inflamed (hepatitis). Researchers think

More information

Autoimmune Hepatitis

Autoimmune Hepatitis Autoimmune Hepatitis National Digestive Diseases Information Clearinghouse U.S. Department of Health and Human Services NATIONAL INSTITUTES OF HEALTH What is autoimmune hepatitis? Autoimmune hepatitis

More information

Autoimmune Hepatitis SG MAITY. 420 Medicine Update

Autoimmune Hepatitis SG MAITY. 420 Medicine Update 420 Medicine Update 73 Autoimmune Hepatitis SG MAITY During the past three decades, remarkable advances have taken place in the understanding of epidemiology, natural history and pathogenesis of chronic

More information

Autoimmune Hepatitis- Better

Autoimmune Hepatitis- Better Autoimmune Hepatitis- Better Understanding 9 : 3 SG Maity, Kolkata Introduction & Definition Autoimmune Hepatitis () is generally considered un-resolving inflammation of liver of unknown cause. Pathologic

More information

Autoimmune Hepatitis

Autoimmune Hepatitis Paul J. Pockros,MD Director of Clinical Research, Scripps Translational Science Institute Director, Liver Disease Center and Senior Consultant Scripps Clinic La Jolla, California Thanks to John Vierling,MD

More information

AASLD PRACTICE GUIDELINES Diagnosis and Treatment of Autoimmune Hepatitis

AASLD PRACTICE GUIDELINES Diagnosis and Treatment of Autoimmune Hepatitis AASLD PRACTICE GUIDELINES Diagnosis and Treatment of Autoimmune Hepatitis Albert J. Czaja 1 and Deborah K. Freese 1,2 Preamble These guidelines provide a data-supported approach to the diagnosis and management

More information

Autoimmune Hepatitis

Autoimmune Hepatitis Autoimmune Hepatitis National Digestive Diseases Information Clearinghouse U.S. Department of Health and Human Services NATIONAL INSTITUTES OF HEALTH What is autoimmune hepatitis? Autoimmune hepatitis

More information

Differentiating between autoimmune hepatitis, primary biliary cirrhosis and overlap syndrome

Differentiating between autoimmune hepatitis, primary biliary cirrhosis and overlap syndrome Differentiating between autoimmune hepatitis, primary biliary cirrhosis and overlap syndrome Dong Hyun Sinn, M.D., Ph.D. Department of Medicine, Samsung Medical Center Sungkyunkwan University School of

More information

Luigi Muratori, MD, PhD Dipartimento di Scienze Mediche e Chirurgiche Policlinico Sant'Orsola via Massarenti, Bologna

Luigi Muratori, MD, PhD Dipartimento di Scienze Mediche e Chirurgiche Policlinico Sant'Orsola via Massarenti, Bologna Luigi Muratori, MD, PhD Dipartimento di Scienze Mediche e Chirurgiche Policlinico Sant'Orsola via Massarenti, 9 40138 Bologna Il sottoscritto dichiara di non aver avuto negli ultimi 12 mesi conflitto d

More information

Autoimmune Hepatitis. Stephan Kanzler II. Department of Medicine Leopoldina Hospital Schweinfurt, Germany

Autoimmune Hepatitis. Stephan Kanzler II. Department of Medicine Leopoldina Hospital Schweinfurt, Germany Autoimmune Hepatitis Stephan Kanzler II. Department of Medicine Leopoldina Hospital Schweinfurt, Germany Falk Symposium 160, Portoroz - 16.06.2007 Autoimmune Liver Diseases AIH OVERLAP PBC/ PSC Autoimmune

More information

Autoimmune Hepatitis and Overlap Syndrome

Autoimmune Hepatitis and Overlap Syndrome Autoimmune Hepatitis and Overlap Syndrome Tram T. Tran, MD, FACG Medical Director, Liver Transplant Associate Professor of Medicine Cedars Sinai Medical Center Autoimmune Hepatitis Demographics and Epidemiology

More information

LCD for Viral Hepatitis Serology Tests

LCD for Viral Hepatitis Serology Tests LCD for Viral Hepatitis Serology Tests Applicable CPT Code(s): 86692 Antibody; Hepatitis, Delta Agent 86704 Hepatitis B Core Antibody (HBcAb); Total 86705 Hepatitis B Core Antibody (HBcAb); IgM Antibody

More information

Drugs Believed Capable of Inducing Autoimmune Hepatitis

Drugs Believed Capable of Inducing Autoimmune Hepatitis Drugs Believed Capable of Inducing Autoimmune Hepatitis Leonard B. Seeff, M.D. National Institutes of Diabetes and Digestive and Kidney Diseases National Institutes of Health Immune-Mediated Liver Diseases

More information

HEPATITIS C DIAGNOSIS AND MANAGEMENT

HEPATITIS C DIAGNOSIS AND MANAGEMENT HEPATITIS C DIAGNOSIS AND MANAGEMENT Introduction The hepatitis C virus (HCV) is one of six viruses (A, B, C, D, E, G) that account for the majority of cases of viral hepatitis. It is responsible for about

More information

Viral Hepatitis Serology Tests

Viral Hepatitis Serology Tests Test Code Test Name CPT HBCOR Hepatitis B Core Total Antibody 86704 (HBcAb) HBCAB Hepatitis B Core Antibody IgM 86705 (HBcAb IgM) HBSAB Hepatitis B Surface Antibody 86706 (HBsAb) HBEAB Hepatitis Be Antibody

More information

Endoscopy in Primary Sclerosing Cholangitis. Stephen M. Lange M.D. Mayo Clinic Jacksonville, FL

Endoscopy in Primary Sclerosing Cholangitis. Stephen M. Lange M.D. Mayo Clinic Jacksonville, FL Endoscopy in Primary Sclerosing Cholangitis Stephen M. Lange M.D. Mayo Clinic Jacksonville, FL Goals Role of ERCP in PSC Initial Diagnosis Complications Managing procedure risks Role of MRCP Endoscopic

More information

Autoimmune Hepatitis. DEIRDRE KELLY ESPGHAN GOES TO AFRICA CAPETOWN October 2013

Autoimmune Hepatitis. DEIRDRE KELLY ESPGHAN GOES TO AFRICA CAPETOWN October 2013 Autoimmune Hepatitis DEIRDRE KELLY ESPGHAN GOES TO AFRICA CAPETOWN October 2013 Autoimmune Hepatitis DEFINITION Progressive necroinflammatory disease Mononuclear infiltrate in the portal tract Increase

More information

Elevated Liver Enzymes Workup, When to Worry, When to Refer

Elevated Liver Enzymes Workup, When to Worry, When to Refer Elevated Liver Enzymes Workup, When to Worry, When to Refer Ontario College of Family Physicians Annual Scientific Assembly Barry Lumb No disclosures Liver Biochemistry Bilirubin Hepatocellular - AST,

More information

Celiac Disease Update

Celiac Disease Update Celiac Disease Update Dominic J. Nompleggi, M.D., Ph.D. Associate Professor of Medicine and Surgery Chief, Division of Gastroenterology University of Massachusetts Medical School Disclosures I have no

More information

Autoimmune Hepatitis

Autoimmune Hepatitis Autoimmune Hepatitis National Digestive Diseases Information Clearinghouse What is autoimmune hepatitis? Autoimmune hepatitis is a chronic or long lasting disease in which the body s immune system attacks

More information

Liver Pathology Questions. Matthew M. Yeh, MD, PhD. 1. Which of the following statements is true regarding hepatitis B?

Liver Pathology Questions. Matthew M. Yeh, MD, PhD. 1. Which of the following statements is true regarding hepatitis B? Liver Pathology Questions 2012 Matthew M. Yeh, MD, PhD 1. Which of the following statements is true regarding hepatitis B? A. Cirrhosis is not a prerequisite for the development of hepatocellular carcinoma.

More information

Anatomy of Liver Normal Liver 6/21/2007

Anatomy of Liver Normal Liver 6/21/2007 Objective Prevention of Liver Cancer Smruti R. Mohanty, MD, MS Assistant Professor of Medicine Center for Liver Diseases Section of Gastroenterology University of Chicago September 6, 2006 Anatomy of Liver

More information

HBV & HCV induced. Liver Cirrhosis Iradj Maleki MD Gut & Liver Research Center Mazandaran University of Medical Sciences

HBV & HCV induced. Liver Cirrhosis Iradj Maleki MD Gut & Liver Research Center Mazandaran University of Medical Sciences HBV & HCV induced Liver Cirrhosis Iradj Maleki MD Gut & Liver Research Center Mazandaran University of Medical Sciences Definition of Cirrhosis Final pathway for a wide variety of chronic liver diseases

More information

Autoimmune Hepatitis: When First Line Therapy Does Not Work

Autoimmune Hepatitis: When First Line Therapy Does Not Work Autoimmune Hepatitis: When First Line Therapy Does Not Work John M. Vierling, M.D., F.A.C.P. Professor of Medicine and Surgery Chief of Hepatology Director of Advanced Liver Therapies Baylor College of

More information

Gastroenterology. Certification Examination Blueprint. Purpose of the exam

Gastroenterology. Certification Examination Blueprint. Purpose of the exam Gastroenterology Certification Examination Blueprint Purpose of the exam The exam is designed to evaluate the knowledge, diagnostic reasoning, and clinical judgment skills expected of the certified gastroenterologist

More information

Approach to Abnormal Liver Tests

Approach to Abnormal Liver Tests Approach to Abnormal Liver Tests Naga P. Chalasani, MD, FACG Professor of Medicine and Cellular & Integrative Physiology Director, Division of Gastroenterology and Hepatology Indiana University School

More information

Acute GVHD: Grading and Endpoints

Acute GVHD: Grading and Endpoints Acute GVHD: Grading and Endpoints Paul Martin, MD Fred Hutchinson Cancer Research Center, Seattle, WA Disclosures Contract support for clinical trials Osiris: Mesenchymal stem cells for secondary treatment

More information

What Is Cirrhosis? CIRRHOSIS. Cirrhosis occurs when the liver is. by chronic conditions and diseases. permanently scarred or injured

What Is Cirrhosis? CIRRHOSIS. Cirrhosis occurs when the liver is. by chronic conditions and diseases. permanently scarred or injured What Is Cirrhosis? Cirrhosis occurs when the liver is permanently scarred or injured by chronic conditions and diseases. Common causes of cirrhosis include: Long-term alcohol abuse. Chronic viral hepatitis

More information

MANAGEMENT OF COMMON SIDE EFFECTS of INH (Isoniazid), RIF (Rifampin), PZA (Pyrazinamide), and EMB (Ethambutol)

MANAGEMENT OF COMMON SIDE EFFECTS of INH (Isoniazid), RIF (Rifampin), PZA (Pyrazinamide), and EMB (Ethambutol) MANAGEMENT OF COMMON SIDE EFFECTS of INH (Isoniazid), RIF (Rifampin), PZA (Pyrazinamide), and EMB (Ethambutol) 1. Hepatotoxicity: In Active TB Disease a. Background: 1. Among the 4 standard anti-tb drugs,

More information

Patterns of abnormal LFTs and their differential diagnosis

Patterns of abnormal LFTs and their differential diagnosis Patterns of abnormal LFTs and their differential diagnosis Professor Matthew Cramp South West Liver Unit and Peninsula Schools of Medicine and Dentistry, Plymouth Summary liver function / liver function

More information

INITIATING ORAL AUBAGIO (teriflunomide) THERAPY

INITIATING ORAL AUBAGIO (teriflunomide) THERAPY FOR YOUR PATIENTS WITH RELAPSING FORMS OF MS INITIATING ORAL AUBAGIO (teriflunomide) THERAPY WARNING: HEPATOTOXICITY AND RISK OF TERATOGENICITY Severe liver injury including fatal liver failure has been

More information

Recommendations for the Diagnosis and Management of Hemochromatosis

Recommendations for the Diagnosis and Management of Hemochromatosis Recommendations for the Diagnosis and Management of Hemochromatosis Individuals with hemochromatosis retain too much iron which may be toxic to the tissues in which it is stored. Acquired hemochromatosis:

More information

NP/PA Clinical Hepatology Fellowship Summary of Year-Long Curriculum

NP/PA Clinical Hepatology Fellowship Summary of Year-Long Curriculum OVERVIEW OF THE FELLOWSHIP The goal of the AASLD NP/PA Fellowship is to provide a 1-year postgraduate hepatology training program for nurse practitioners and physician assistants in a clinical outpatient

More information

Evaluation of Liver Function tests in Primary Care. Abid Suddle Institute of Liver Studies, KCH

Evaluation of Liver Function tests in Primary Care. Abid Suddle Institute of Liver Studies, KCH Evaluation of Liver Function tests in Primary Care Abid Suddle Institute of Liver Studies, KCH Liver Function tests Markers of hepatocellular damage Cholestasis Liver synthetic function Markers of Hepatocellular

More information

GI & Liver Disease Testing By Doctors For Doctors

GI & Liver Disease Testing By Doctors For Doctors GI & Liver Disease Testing By Doctors For Doctors Updated September 2013 GI & Liver Disease Panels Autoimmune GI Panels Inflammatory Bowel Disease Panel RDL s Inflammatory Bowel Disease (IBD) Panel combines

More information

Alcoholic and Non-Alcoholic Fatty Liver Disease

Alcoholic and Non-Alcoholic Fatty Liver Disease Alcoholic and Non-Alcoholic Fatty Liver Disease Thomas W. Faust, M.D., M.B.E. Professor of Clinical Medicine Division of Gastroenterology The University of Pennsylvania Alcoholic Liver Disease Additional

More information

Excess iron may accumulate in these 3 normal storage sites and also in other organs that don t normally store iron, such as the:

Excess iron may accumulate in these 3 normal storage sites and also in other organs that don t normally store iron, such as the: What is Iron Overload? Iron overload occurs when you have too much iron in your body. This can be a problem for people who get lots of red blood cell transfusions. Red blood cells contain iron. Each time

More information

Learning Objectives. Non-alcoholic Fatty Liver Disease (NAFLD) (Fatty Liver) What is Fatty Liver (Non-Alcoholic Fatty Liver)? Fatty Liver (NAFLD)

Learning Objectives. Non-alcoholic Fatty Liver Disease (NAFLD) (Fatty Liver) What is Fatty Liver (Non-Alcoholic Fatty Liver)? Fatty Liver (NAFLD) Learning Objectives Non-alcoholic Fatty Liver Disease (NAFLD) (Fatty Liver) Smruti R. Mohanty, MD, MS Assistant Professor of Medicine Center for Liver Diseases Section of Gastroenterology University of

More information

Autoimmune Pancreatitis Presenting with Jaundice

Autoimmune Pancreatitis Presenting with Jaundice Autoimmune Pancreatitis Presenting with Jaundice Salil Garg, Harvard Medical School, Year III Gillian Lieberman, M.D. Our patient: A 73 yo male presenting with obstructive jaundice, history of autoimmune

More information

1/13/2017. Blood work... when to worry? Part 2. Bryan E. Martin MD Medical Director Benefis Sletten Cancer Institute. Blood work When to worry?

1/13/2017. Blood work... when to worry? Part 2. Bryan E. Martin MD Medical Director Benefis Sletten Cancer Institute. Blood work When to worry? Blood work... when to worry? Part 2 Bryan E. Martin MD Medical Director Benefis Sletten Cancer Institute Blood work When to worry? part 2 Abnormal Iron Studies Abnormal Globulin Tumor markers...next time

More information

To provide advice on safe prescribing and monitoring of 6-mercaptopurine for use in the management of inflammatory bowel disease.

To provide advice on safe prescribing and monitoring of 6-mercaptopurine for use in the management of inflammatory bowel disease. Gastroenterology Shared Care Guideline 6-Mercaptopurine - In Inflammatory Bowel Disease 1 Scope Prescribing and monitoring by General Practitioners. 2 Purpose To provide advice on safe prescribing and

More information

AASLD PRACTICE GUIDELINES Diagnosis and Management of Autoimmune Hepatitis

AASLD PRACTICE GUIDELINES Diagnosis and Management of Autoimmune Hepatitis AASLD PRACTICE GUIDELINES Diagnosis and Management of Autoimmune Hepatitis Michael P. Manns, 1 Albert J. Czaja, 2 James D. Gorham, 3 Edward L. Krawitt, 4 Giorgina Mieli-Vergani, 5 Diego Vergani, 6 and

More information

The child with abnormal liver function tests

The child with abnormal liver function tests The child with abnormal liver function tests Dr Jane Hartley Consultant Paediatric Hepatologist Birmingham Children s Hospital, UK 1 st Global Congress CIP, Paris 2011 Contents Over view of liver anatomy,

More information

Primary Care Approach to Diagnosis and Management of Chronic Hepatitis C Brian Viviano, D.O.

Primary Care Approach to Diagnosis and Management of Chronic Hepatitis C Brian Viviano, D.O. Primary Care Approach to Diagnosis and Management of Chronic Hepatitis C Brian Viviano, D.O. Objectives Epidemiology of chronic hepatitis C CDC guidelines on screening or hepatitis C Diagnosing hepatitis

More information

TREATING AUTOIMMUNE DISEASES WITH HOMEOPATHY. Dr. Stephen A. Messer, MSEd, ND, DHANP Professor and Chair of Homeopathic Medicine

TREATING AUTOIMMUNE DISEASES WITH HOMEOPATHY. Dr. Stephen A. Messer, MSEd, ND, DHANP Professor and Chair of Homeopathic Medicine TREATING AUTOIMMUNE DISEASES WITH HOMEOPATHY Dr. Stephen A. Messer, MSEd, ND, DHANP Professor and Chair of Homeopathic Medicine AUTOIMMUNE DISEASES An autoimmune disorder occurs when the body s immune

More information

Autoimmune Pancreatitis: When to suspect How to Diagnose and How to Treat

Autoimmune Pancreatitis: When to suspect How to Diagnose and How to Treat Autoimmune Pancreatitis: When to suspect How to Diagnose and How to Treat Suresh T. Chari, MD Head, Pancreas Interest Group Professor, Division of Gastroenterology & Hepatology Mayo Clinic College of Medicine,

More information

190.33 - Hepatitis Panel/Acute Hepatitis Panel

190.33 - Hepatitis Panel/Acute Hepatitis Panel 190.33 - Hepatitis Panel/Acute Hepatitis Panel This panel consists of the following tests: Hepatitis A antibody (HAAb), IgM antibody; Hepatitis B core antibody (HBcAb), IgM antibody; Hepatitis B surface

More information

Appendix B: Provincial Case Definitions for Reportable Diseases

Appendix B: Provincial Case Definitions for Reportable Diseases Infectious Diseases Protocol Appendix B: Provincial Case Definitions for Reportable Diseases Disease: Hepatitis A Revised December 2014 Hepatitis A 1.0 Provincial Reporting Confirmed and probable cases

More information

Hepatitis End of Module Quiz (9 Questions)

Hepatitis End of Module Quiz (9 Questions) Hepatitis End of Module Quiz (9 Questions) 1. Which of the following is true regarding hepatitis? A. Hepatitis means inflammation B. Hepatitis can result from both infectious and non-infectious causes

More information

Abnormal Liver Tests and Fatty Liver Disease

Abnormal Liver Tests and Fatty Liver Disease Abnormal Liver Tests and Fatty Liver Disease Michael D Voigt MD Medical Director Liver Failure and Transplantation, University of Iowa Hospital and Clinics Conflict of interest: I sadly have nothing to

More information

Alanine aminotransferase test

Alanine aminotransferase test Alanine aminotransferase test Also known as: Serum glutamic-pyruvic transaminase, SGPT or ALT The alanine aminotransferase test, also known as ALT, is one of a group of tests known as liver function tests

More information

Chapter 9. Hepatitis inflammation of the liver. M.G.Rajanandh, Dept. of Pharmacy Practice, SRM College of Pharmacy, SRM University.

Chapter 9. Hepatitis inflammation of the liver. M.G.Rajanandh, Dept. of Pharmacy Practice, SRM College of Pharmacy, SRM University. Chapter 9 Hepatitis inflammation of the liver M.G.Rajanandh, Dept. of Pharmacy Practice, SRM College of Pharmacy, SRM University. Can have many causes drugs toxins alcohol viral infections (A, B, C, D,

More information

Promacta. Promacta (eltrombopag) Description

Promacta. Promacta (eltrombopag) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.10.15 Subject: Promacta Page: 1 of 6 Last Review Date: September 18, 2015 Promacta Description Promacta

More information

Metabolic Disorders , The Patient Education Institute, Inc. idg90101 Last reviewed: 08/14/2014 1

Metabolic Disorders , The Patient Education Institute, Inc.  idg90101 Last reviewed: 08/14/2014 1 Metabolic Disorders Introduction Metabolism is the process your body uses to make energy from the food you eat. Your body can use this fuel right away, or it can store the energy in your body tissues,

More information

GASTROENTEROLOGY Maintenance of Certification (MOC) Examination Blueprint

GASTROENTEROLOGY Maintenance of Certification (MOC) Examination Blueprint GASTROENTEROLOGY Maintenance of Certification (MOC) Examination Blueprint ABIM invites diplomates to help develop the Gastroenterology MOC exam blueprint Based on feedback from physicians that MOC assessments

More information

Adverse Drug Reaction of TB Medications

Adverse Drug Reaction of TB Medications Adverse Drug Reaction of TB Medications Supha Arthurs, MD 2014 MFMER slide-1 Objectives Recognize the common side effects of first line tuberculosis medication Know the risk factors, associated drugs,

More information

Pathophysiology. Asst. Prof. Dr. Dalya Basil. Disorders of GIT and Hepatobiliary System

Pathophysiology. Asst. Prof. Dr. Dalya Basil. Disorders of GIT and Hepatobiliary System Pathophysiology Lecture 15 Asst. Prof. Dr. Dalya Basil Disorders of GIT and Hepatobiliary System Viral Hepatitis: is a liver inflammation caused by five unrelated hepatotropic viruses Hepatitis A, Hepatitis

More information

Alanine aminotransferase (serum, plasma)

Alanine aminotransferase (serum, plasma) Alanine aminotransferase (serum, plasma) 1 Name and description of analyte 1.1 Name of analyte Alanine aminotransferase (ALT) 1.2 Alternative names Systematic name L alanine:2 oxoglutarate aminotransferase

More information

Myositis and Your Lungs

Myositis and Your Lungs Myositis and Your Lungs 2011 TMA Annual Meeting Las Vegas, Nevada Chester V. Oddis, MD University of Pittsburgh Myositis Heterogeneous group of autoimmune syndromes characterized by chronic muscle weakness

More information

Elements for a Public Summary

Elements for a Public Summary VI.2 VI.2.1 Elements for a Public Summary Overview of disease epidemiology Gastro-oesophageal reflux disease (GERD), reflux oesophagitis: GERD is defined by the presence of symptoms resulting from abnormal

More information

A challenging case of Lupus Mesenteric Vasculitis. Pooja Kumari, MD Sonali Khandelwal, MD

A challenging case of Lupus Mesenteric Vasculitis. Pooja Kumari, MD Sonali Khandelwal, MD A challenging case of Lupus Mesenteric Vasculitis Pooja Kumari, MD Sonali Khandelwal, MD Case presentation 41 year old male with PMH of antiphospholipid syndrome, Sjogren's syndrome, Systemic lupus erythematous,

More information

Goals of Therapy. Treatment Options for Hepatitis C. Patterns of Response. Progress in Hepatitis C Therapy

Goals of Therapy. Treatment Options for Hepatitis C. Patterns of Response. Progress in Hepatitis C Therapy Treatment Options for Hepatitis C Helen S. Te, M.D. Center for Liver Diseases University of Chicago Hospitals Chicago, Illinois Primary: To eliminate the virus Goals of Therapy Secondary: To decrease inflammation

More information

Serum & urine protein electrophoresis

Serum & urine protein electrophoresis Serum & urine protein electrophoresis Take a test Normal or abnormal? Definitions Electrophoresis is a method of separating proteins based on their physical properties. Serum is placed on a specific

More information

The ANA Test: All You Need to Know Department of Family and Community Medicine Family Medicine Update April 25, 2014

The ANA Test: All You Need to Know Department of Family and Community Medicine Family Medicine Update April 25, 2014 The ANA Test: All You Need to Know Department of Family and Community Medicine Family Medicine Update April 25, 2014 Celso R. Velázquez MD Division of Rheumatology University of Missouri velazquezc@health.missouri.edu

More information

Management of Complications of NASH: When to Biopsy? How to Treat? Assistant Professor University of Pittsburgh Medical Center.

Management of Complications of NASH: When to Biopsy? How to Treat? Assistant Professor University of Pittsburgh Medical Center. Management of Complications of NASH: When to Biopsy? How to Treat? Alison Jazwinski, MD, MHS Assistant Professor University of Pittsburgh Medical Center Clinical Case 31 yo female referred for evaluation

More information

HBV: Update and Treatment Guidelines

HBV: Update and Treatment Guidelines HBV: Update and Treatment Guidelines Virginia Clark, MD, MS Assistant Professor of Medicine Division of Gastroenterology, Hepatology, and Nutrition University of Florida Learning Objective Identify the

More information

Evaluation of a Child with Elevated Transaminases. Linda V. Muir, M.D. April 11, 2008 Northwest Pediatric Liver Disease Symposium

Evaluation of a Child with Elevated Transaminases. Linda V. Muir, M.D. April 11, 2008 Northwest Pediatric Liver Disease Symposium Evaluation of a Child with Elevated Transaminases Linda V. Muir, M.D. April 11, 2008 Northwest Pediatric Liver Disease Symposium Disclosures I do not have a financial interest, arrangement or affiliation

More information

Hepatitis A. Contraindications. General. Hepatitis A vaccines (WHO position paper)

Hepatitis A. Contraindications. General. Hepatitis A vaccines (WHO position paper) Contraindications Contraindications to hepatitis A vaccination include a known allergy to any of the vaccine components. General Currently, four inactivated vaccines against HAV are internationally available.

More information

Hepatitis. Objectives. General term for inflammation of the liver. Can be due to non-infectious causes such as:

Hepatitis. Objectives. General term for inflammation of the liver. Can be due to non-infectious causes such as: Laboratory Diagnosis & Monitoring of Infectious Hepatitis Objectives Compare and contrast the major types of hepatitis viruses and explain the disease transmission and progression processes in viral hepatitis

More information

Good Morning! September 9, 2014

Good Morning! September 9, 2014 Good Morning! September 9, 2014 Prep! A 5 day old infant was found in a trash dumpster and is brought to you for evaluation. Because you have no history on the baby, you decide to send serology specimens

More information

hepatitisc Chronic hepatitis C Between 75 and 80% of all patients infected with CHAPTER 4 AN UPDATE The size of the problem Diagnosis of chronic HCV

hepatitisc Chronic hepatitis C Between 75 and 80% of all patients infected with CHAPTER 4 AN UPDATE The size of the problem Diagnosis of chronic HCV CHAPTER 4 hepatitisc Chronic hepatitis C Between 75 and 80% of all patients infected with the hepatitis C virus (HCV) develop chronic infection which is defined as infection persisting for more than six

More information

LIVER FUNCTION ABNORMALITIES FALL INTO 2 MAIN GROUPS: 1) HEPATIC INJURY 2) CHOLESTATIC

LIVER FUNCTION ABNORMALITIES FALL INTO 2 MAIN GROUPS: 1) HEPATIC INJURY 2) CHOLESTATIC HEPATIC DISEASE LIVER FUNCTION ABNORMALITIES FALL INTO 2 MAIN GROUPS: 1) HEPATIC INJURY 2) CHOLESTATIC LFT s HEPATIC INJURY: ALT (5-40) AST (5-40) CHOLESTASIS: ALP (30-120) & GGT (5-65) (together) NONSPECIFIC

More information

Sjögren's Syndrome. Sjögren's Syndrome Page 1

Sjögren's Syndrome. Sjögren's Syndrome Page 1 Sjögren's Syndrome In the early 20th century, Swedish physician Henrik Sjögren (SHOW gren) first described a group of women whose chronic arthritis was accompanied by dry eyes and dry mouth. Today rheumatologists

More information

Transplantation. David Howell, M.D., Ph.D. Duke University Medical Center Durham, North Carolina

Transplantation. David Howell, M.D., Ph.D. Duke University Medical Center Durham, North Carolina Transplantation David Howell, M.D., Ph.D. Duke University Medical Center Durham, North Carolina Objectives List and define the various types of donor-recipient organ transplant combinations, organ graft

More information

Liver Function Essay

Liver Function Essay Liver Function Essay Name: Quindoline Ntui Date: April 20, 2009 Professor: Dr. Danil Hammoudi Class: Anatomy and Physiology 2 Liver function The human body consist of many highly organize part working

More information

Liver Failure and Liver Disease. Acetaminophen-induced acute liver failure Results of a United States multicenter, prospective study

Liver Failure and Liver Disease. Acetaminophen-induced acute liver failure Results of a United States multicenter, prospective study Liver Failure and Liver Disease 1 Acetaminophen-induced acute liver failure Results of a United States multicenter, prospective study Hepatology (American Association for the Study of Liver Diseases) November

More information

Liver, Gallbladder and Pancreas diseases. Premed 2 Pathophysiology

Liver, Gallbladder and Pancreas diseases. Premed 2 Pathophysiology Liver, Gallbladder and Pancreas diseases Premed 2 Pathophysiology Pancreas Pancreatitis Acute Pancreatitis Autodigestion of the pancreas due to activation of the enzymes Hemorrhagic fat necrosis, calcium

More information

Proteins. Learning Objectives. Optimizing electrophoresis

Proteins. Learning Objectives. Optimizing electrophoresis Proteins Michael A. Pesce, Ph.D Director of the Specialty Laboratory New York-Presbyterian Hospital Clinical professor of Pathology Columbia University Medical Center Learning Objectives Describe the electrophoresis

More information

Bile Duct Diseases and Problems

Bile Duct Diseases and Problems Bile Duct Diseases and Problems Introduction A bile duct is a tube that carries bile between the liver and gallbladder and the intestine. Bile is a substance made by the liver that helps with digestion.

More information

Non-alcoholic Fatty Liver Disease. Christi Matteoni, MD GI Consultants

Non-alcoholic Fatty Liver Disease. Christi Matteoni, MD GI Consultants Non-alcoholic Fatty Liver Disease Christi Matteoni, MD GI Consultants Definition of NAFLD Evidence of hepatic steatosis by imaging or histology No causes for secondary hepatic fat accumulation Significant

More information

NEW PROPOSED IDSURV CASE DEFINITION

NEW PROPOSED IDSURV CASE DEFINITION NEW PROPOSED IDSURV CASE DEFINITION CHICKEN POX A febrile illness with acute onset of diffuse (generalized) maculopapulo- vesicular rash starting from trunk and spreading to extremities in multiple stages

More information

INFLAMMATORY BOWEL DISEASE. Jean-Paul Achkar, M.D. Cleveland Clinic Foundation Cleveland, OH

INFLAMMATORY BOWEL DISEASE. Jean-Paul Achkar, M.D. Cleveland Clinic Foundation Cleveland, OH INFLAMMATORY BOWEL DISEASE Jean-Paul Achkar, M.D. Cleveland Clinic Foundation Cleveland, OH 1. What is inflammatory bowel disease? Inflammatory bowel disease (IBD) refers to two related but different diseases:

More information

2015 Outpatient Chronic Hepatitis B Management

2015 Outpatient Chronic Hepatitis B Management 2015 Outpatient Chronic Hepatitis B Management Hepatitis B Hepatitis B Info 70% of acute infections are subclinical More severe symptoms when in addition to other liver disease Fulminant Hepatitis

More information

Indicate whether the case had jaundice. If not known or unavailable then select the Unknown option.

Indicate whether the case had jaundice. If not known or unavailable then select the Unknown option. HBC-1 HEPATITIS B, C, NOS Disease name Disease Indicate whether the case is hepatitis B, C or NOS (Not Otherwise Specified). Select hepatitis NOS for cases of hepatitis D, hepatitis E or if the type of

More information

Alcoholic Liver Disease

Alcoholic Liver Disease Alcoholic Hepatitis Paul Y. Kwo, MD Professor of Medicine i Medical Director, Liver Transplantation Gastroenterology/Hepatology Division Indiana University School of Medicine 975 W. Walnut, IB 327 Indianapolis,

More information

1. Which one of the following statements concerning febuxostat in the treatment of gout is

1. Which one of the following statements concerning febuxostat in the treatment of gout is Chapter 59. Gout and Hyperuricemia, Self-Assessment Questions 1. Which one of the following statements concerning febuxostat in the treatment of gout is correct? A. It is more effective in reducing acute

More information

Case Discussions: Managing Toxicities of Anti TB Medications

Case Discussions: Managing Toxicities of Anti TB Medications Case Discussions: Managing Toxicities of Anti TB Medications Henry Fraimow, MD Division of Infectious Diseases, Cooper University Hospital, Camden, NJ Medical Consultant, Southern New Jersey Regional Chest

More information

Pathophysiology of Alcoholic. Consultant Gastroenterologist Wishaw General Hospital

Pathophysiology of Alcoholic. Consultant Gastroenterologist Wishaw General Hospital Pathophysiology of Alcoholic Liver disease. Beth Reed Consultant Gastroenterologist Wishaw General Hospital MG 35 yr old class room assistant No sig PMHx has never been to hospitial No regular medication

More information

Lab. And diagnosis S.L.E. Dr.noori Rheumatologist

Lab. And diagnosis S.L.E. Dr.noori Rheumatologist Lab. And diagnosis S.L.E Dr.noori Rheumatologist The onset of lupus may be acute, resembling an infectious process, or it may be a progression of vague symptoms over several years. As a result, diagnosing

More information

Update on Hepatitis C. Sally Williams MD

Update on Hepatitis C. Sally Williams MD Update on Hepatitis C Sally Williams MD Hep C is Everywhere! Hepatitis C Magnitude of the Infection Probably 8 to 10 million people in the U.S. are infected with Hep C 30,000 new cases are diagnosed annually;

More information

Wendy Carter, DO Medical Officer Division of Antiviral Products, FDA

Wendy Carter, DO Medical Officer Division of Antiviral Products, FDA Wendy Carter, DO Medical Officer Division of Antiviral Products, FDA Click to view Biosketch and Presentation Abstract or page down to review presentation Evaluation of Transaminase Elevations in Subjects

More information

IS CAUSED BY VIRUSES BUT CAN ALSO BE CAUSED BY AMOEBA AND TOXIC CHEMICALS.

IS CAUSED BY VIRUSES BUT CAN ALSO BE CAUSED BY AMOEBA AND TOXIC CHEMICALS. HEPATITIS (INFLAMMATION OF THE LIVER) IS CAUSED BY VIRUSES BUT CAN ALSO BE CAUSED BY AMOEBA AND TOXIC CHEMICALS. HEPATITIS A FORMERLY KNOWN AS INFECTIOUS HEPATITIS IS CAUSED BY ss RNA VIRUS OF THE Picornaviridae

More information

2015 Hepatitis C Sovaldi [sofosbuvir]) Prior Authorization Through Preferred Agent(s) Program Summary

2015 Hepatitis C Sovaldi [sofosbuvir]) Prior Authorization Through Preferred Agent(s) Program Summary 2015 Hepatitis C Sovaldi [sofosbuvir]) Prior Authorization Through Preferred Agent(s) Program Summary 2015 Hepatitis C Sovaldi [sofosbuvir]) Prior Authorization Through Preferred Pegylated Interferon The

More information

Primary Liver Cancer. What is the liver? What is cancer?

Primary Liver Cancer. What is the liver? What is cancer? Primary Liver Cancer Primary liver cancer is where the cancer originates in the liver. It is a common cancer worldwide and its incidence is increasing in the USA. Most cases develop in the setting of liver

More information

Prior Authorization Conditions for Approval of Hepatitis C Agents

Prior Authorization Conditions for Approval of Hepatitis C Agents Prior Authorization Conditions for Approval of Hepatitis C Agents All requests for Hepatitis C Agents require a prior authorization and will be screened for medical necessity and appropriateness using

More information

PIERO LUIGI ALMASIO CATTEDRA DI GASTROENTEROLOGIA UNIVERSITA OF PALERMO

PIERO LUIGI ALMASIO CATTEDRA DI GASTROENTEROLOGIA UNIVERSITA OF PALERMO Steatosi e Steatoepatite PIERO LUIGI ALMASIO CATTEDRA DI GASTROENTEROLOGIA UNIVERSITA OF PALERMO Alcoholic liver disease Liver damage resulting from long-term alcohol consumption Histological features:

More information

Iron deficiency anaemia: Management in chronic kidney disease with intravenous iron (Ferinject )

Iron deficiency anaemia: Management in chronic kidney disease with intravenous iron (Ferinject ) Clinical guideline Iron deficiency anaemia: Management in chronic kidney disease with intravenous iron (Ferinject ) Anaemia is a common feature of chronic kidney disease (CKD). Iron therapy is used to

More information

Liver Diseases. An Essential Guide for Nurses and Health Care Professionals

Liver Diseases. An Essential Guide for Nurses and Health Care Professionals Brochure More information from http://www.researchandmarkets.com/reports/1047385/ Liver Diseases. An Essential Guide for Nurses and Health Care Professionals Description: Liver disease is a rapidly growing

More information

Immunomodulators and Biologics for Inflammatory Bowel Disease

Immunomodulators and Biologics for Inflammatory Bowel Disease Immunomodulators and Biologics for Inflammatory Bowel Disease Patient Information The cause of IBD is unknown. The immune system of the intestine becomes overactive. Medicines to suppress the immune system

More information